[{"Physician_Profile_ID": "604519", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "640.06", "Date_of_Payment": "09/04/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "247859894", "Name_of_Associated_Covered_Drug_or_Biological1": "MENHIBRIX", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "MENACWY TT 057 PRI", "Research_Information_Link": "", "Context_of_Research": ""}, {"Physician_Profile_ID": "604519", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "633.04", "Date_of_Payment": "12/22/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "208664322", "Name_of_Associated_Covered_Drug_or_Biological1": "NIMENRIX", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "MenACWY TT 057 PRI", "Research_Information_Link": "", "Context_of_Research": ""}]